A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors

Clinical trial NCT03854227 · TERMINATED

Trial details

NCT number: NCT03854227
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Metastatic Solid Tumors

Start date: 2019-03-14
Primary completion: 2022-04-27
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.